Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T19:46:59.626Z.
Calculation as of: 2026-10-06T19:46:59.626Z.
Quote observation: 2026-10-06T19:45:19.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e7bb4fe4bb3aa983eb4620adc8aa5d0f555a5020ff21ce65ee2b72f9631e0f85
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
Market Cap
$2.77B
Price/OCF Ratio
19.00
TTM Avg
24.35
3Y Avg
65.42
5Y Avg
65.42
Market Cap
$3.00B
Price/OCF Ratio
76.20
TTM Avg
106.08
3Y Avg
106.08
5Y Avg
106.08
Market Cap
$2.69B
Price/OCF Ratio
12.80
TTM Avg
10.38
3Y Avg
21.92
5Y Avg
19.88
Market Cap
$3.05B
Price/OCF Ratio
N/A
TTM Avg
16.06
3Y Avg
20.39
5Y Avg
20.39
Market Cap
$2.68B
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dyne Therapeutics, Inc. (DYN) | $2.85B | N/A | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $2.77B | 19.00 | 24.35 | 65.42 | 65.42 |
| AtriCure, Inc. (ATRC)vs › | $2.73B | 42.01 | 33.50 | 475.62 | 475.62 |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.00B | 76.20 | 106.08 | 106.08 | 106.08 |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.00B | N/A | N/A | N/A | N/A |
| Precigen, Inc. (PGEN)vs › | $2.70B | N/A | 127.17 | 127.17 | 127.17 |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | 12.80 | 10.38 | 21.92 | 19.88 |
| Denali Therapeutics Inc. (DNLI)vs › | $3.05B | N/A | 16.06 | 20.39 | 20.39 |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.68B | N/A | N/A | N/A | N/A |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.65B | 15.76 | 17.24 | 48.15 | 48.31 |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
